Gene · 6197
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Pleiotropic Face of CREB Family Transcription Factors. | Mol Cells | 2023 | 37013623 | PubTator, text mining | PubMed |
| Target-driven machine learning-enabled virtual screening (TAME-VS) platform for early-stage hit identification. | Front Mol Biosci | 2023 | 36994428 | PubTator, text mining | PubMed |
| Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes. | Nat Commun | 2023 | 36991000 | PubTator, text mining | PubMed |
| Pharmacology-Based Prediction of the Targets and Mechanisms for Icariin against Myocardial Infarction. | Medicina (Kaunas) | 2023 | 36984421 | PubTator, text mining | PubMed |
| Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and Perspectives. | Cancers (Basel) | 2023 | 36980566 | PubTator, text mining | PubMed |
| Evaluation of Individuals with Non-Syndromic Global Developmental Delay and Intellectual Disability. | Children (Basel) | 2023 | 36979972 | PubTator, text mining | PubMed |
| Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis. | Front Oncol | 2023 | 36969076 | PubTator, text mining | PubMed |
| Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment. | Mol Cancer | 2023 | 36966334 | PubTator, text mining | PubMed |
| Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics. | Biomed Pharmacother | 2023 | 36916400 | PubTator, text mining | PubMed |
| Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer. | Oncol Lett | 2023 | 36909377 | PubTator, text mining | PubMed |
| Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 36902316 | PubTator, text mining | PubMed |
| Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. | Int J Mol Sci | 2023 | 36901717 | PubTator, text mining | PubMed |
| RSK inhibitors as potential anticancer agents: Discovery, optimization, and challenges. | Eur J Med Chem | 2023 | 36898330 | PubTator, text mining | PubMed |
| MiR-760 targets HBEGF to control cartilage extracellular matrix degradation in osteoarthritis. | J Orthop Surg Res | 2023 | 36894989 | PubTator, text mining | PubMed |
| mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer. | JCI Insight | 2023 | 36883564 | PubTator, text mining | PubMed |
| Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A. | Nat Commun | 2023 | 36854761 | PubTator, text mining | PubMed |
| Hypoxia-induced downregulation of microRNA-186-5p in endothelial cells promotes non-small cell lung cancer angiogenesis by upregulating protein kinase C alpha. | Mol Ther Nucleic Acids | 2023 | 36845338 | PubTator, text mining | PubMed |
| Orthologs of Human-Disease-Associated Genes in Plants Are Involved in Regulating Leaf Senescence. | Life (Basel) | 2023 | 36836919 | PubTator, text mining | PubMed |
| L-Carnitine and Chronic Kidney Disease: A Comprehensive Review on Nutrition and Health Perspectives. | J Pers Med | 2023 | 36836532 | PubTator, text mining | PubMed |
| A stay of execution: ATF4 regulation and potential outcomes for the integrated stress response. | Front Mol Neurosci | 2023 | 36825279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6197/papers?page=10